
|Articles|February 2, 2012
Dr. Niteesh Choudhry Discusses Value-Based Insurance Design [Part 1 of 4]
Advertisement
Dr. Niteesh Choudhry, Associate Professor, Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics in Boston, discusses VBID and how looming questions revealed from this study show the model’s importance as well as its need to be better defined.
Dr. Choudhry explains that a key method to better defining VBID is to conduct similar studies within other specialties to learn about outcomes when the model is applied to diseases such as diabetes, hypertension, and hyperlipidemia.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Cicada COVID-19 Variant FAQs: Symptoms, Risk, and Prevention
2
INHALE-1 Findings Support Inhaled Insulin as a Viable Option for Pediatric Patients: Kevin Kaiserman, MD
3
First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD
4
AI Reshaping Diabetes Care From Nutrition to Clinical Decisions
5


